Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 3/20 | 0.44 |
| ▸ | NR1H3 | Q13133 | 3/20 | 0.44 |
| ▸ | KLK7 | P49862 | 1/20 | 0.42 |
| ▸ | FKBP1A | P62942 | 2/20 | 0.41 |
| ▸ | CCR5 | P51681 | 4/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.40 |
| ▸ | STS | P08842 | 1/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | ANPEP | P15144 | 1/20 | 0.40 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.40 |
| ▸ | JAK2 | O60674 | 1/20 | 0.38 |
| ▸ | JAK1 | P23458 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30695869 | 0.92 | CCR5 (0.42) | NR1H2NR1H3KLK7CCR5MCL1 | |
| SCHEMBL23668282 | 0.92 | NR1H2 (0.42) | NR1H2NR1H3KLK7CCR5MCL1 | |
| SCHEMBL23668279 | 0.83 | CCR5 (0.43) | KLK7CCR5MCL1 | |
| SCHEMBL28577303 | 0.79 | MMP2 (0.46) | FKBP1ACCR5MMP2ANPEP | |
| SCHEMBL30695875 | 0.78 | MAPK1 (0.41) | CCR5MMP2ANPEP | |
| SCHEMBL23632315 | 0.78 | KLK7 (0.52) | NR1H2NR1H3KLK7FKBP1AMCL1 | |
| SCHEMBL15287962 | 0.78 | KLK7 (0.41) | KLK7FKBP1AMCL1 | |
| SCHEMBL15347003 | 0.78 | KLK7 (0.41) | KLK7FKBP1AMCL1 | |
| SCHEMBL15347117 | 0.78 | MEN1 (0.43) | KLK7MCL1PTPN1JAK2JAK1 | |
| SCHEMBL20009192 | 0.78 | KLK7 (0.42) | KLK7FKBP1AJAK2JAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3854786-B1 | METHOD FOR PRODUCING AMINO ACID DERIVATIVES | UBE CORP (JP) | 2026-02-18 | — | — | EP | disclosed |
| US-12281074-B2 | Method for producing amino acid derivatives | UBE CORPORATION (JP) | 2025-04-22 | — | — | US | disclosed |
| CN-119707784-A | Process for preparing amino acid derivatives | 株式会社API | 2025-03-28 | — | — | CN | disclosed |
| US-12202800-B2 | Method for producing amino acid derivatives | API CORPORATION (JP) | 2025-01-21 | — | — | US | disclosed |
| CN-112930338-B | Process for preparing amino acid derivatives | 株式会社API | 2024-12-24 | — | — | CN | disclosed |
| US-20240150292-A1 | METHOD FOR PRODUCING AMINO ACID DERIVATIVES | API CORPORATION (JP) | 2024-05-09 | — | — | US | disclosed |
| US-11897844-B2 | Method for producing amino acid derivatives | API CORPORATION (JP) | 2024-02-13 | — | — | US | disclosed |
| US-20240002340-A1 | METHOD FOR PRODUCING AMINO ACID DERIVATIVES | API CORPORATION (JP) | 2024-01-04 | — | — | US | disclosed |
| CN-112930338-A | Process for the preparation of amino acid derivatives | 株式会社API | 2021-06-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240150292-A1 | METHOD FOR PRODUCING AMINO ACID DERIVATIVES | PTGS2, PTGES, PTGS1 | NR1H2 3651/4885NR1H3 3278/4885KLK7 3640/4885 |
| US-12202800-B2 | Method for producing amino acid derivatives | GLO1, BCAT2, BCAT1 | NR1H2 2980/4885NR1H3 2829/4885KLK7 2474/4885 |
| US-20240002340-A1 | METHOD FOR PRODUCING AMINO ACID DERIVATIVES | GLO1, BCAT2, BCAT1 | NR1H2 2980/4885NR1H3 2829/4885KLK7 2474/4885 |
| US-11897844-B2 | Method for producing amino acid derivatives | PTGS2, PTGES, PTGES2 | NR1H2 3824/4885NR1H3 3530/4885KLK7 3712/4885 |
| US-12281074-B2 | Method for producing amino acid derivatives | PTGS2, PTGES, PTGES2 | NR1H2 3824/4885NR1H3 3530/4885KLK7 3712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.